BLRX - BioLine RX Ltd (BLRX) CEO Philip Serlin on Q2 2020 Results - Earnings Call Transcript
BioLine RX Ltd (BLRX)
Q2 2020 Earnings Conference Call
August 06, 2020, 10:00 ET
Company Participants
Timothy McCarthy - LifeSci Advisors
Philip Serlin - CEO
Mali Zeevi - CFO
Abi Vainstein - VP, Clinical Development
Conference Call Participants
Joseph Pantginis - H.C. Wainwright & Co.
Mark Breidenbach - Oppenheimer
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Second Quarter 2020 Results Conference Call. [Operator Instructions].
I would now like to turn the call over to Timothy McCarthy of LifeSci Advisors to read the safe harbor statement. Tim, please go